Search Legislation

Council Directive 93/42/EECShow full title

Council Directive 93/42/EEC of 14 June 1993 concerning medical devices

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

ANNEX IXU.K.CLASSIFICATION CRITERIA

I.DEFINITIONSU.K.

1.Definitions for the classification rulesU.K.

1.1.DurationU.K.
TransientU.K.

Normally intended for continuous use for less than 60 minutes.

Short termU.K.

Normally intended for continuous use for not more than 30 days.

Long termU.K.

Normally intended for continuous use for more than 30 days.

1.2.Invasive devicesU.K.
Invasive deviceU.K.

A device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body.

Body orificeU.K.

Any natural opening in the body, as well as the external surface of the eyeball, or any permanent artificial opening, such as a stoma.

Surgically invasive deviceU.K.

An invasive device which penetrates inside the body through the surface of the body, with the aid or in the context of a surgical operation.

For the purposes of this Directive devices other than those referred to in the previous subparagraph and which produce penetration other than through an established body orifice, shall be treated as surgically invasive devices.

Implantable deviceU.K.

Any device which is intended:

  • to be totally introduced into the human body or,

  • to replace an epithelial surface or the surface of the eye,

by surgical intervention which is intended to remain in place after the procedure.

Any device intended to be partially introduced into the human body through surgical intervention and intended to remain in place after the procedure for at least 30 days is also considered an implantable device.

1.3.Reusable surgical instrumentU.K.

Instrument intended for surgical use by cutting, drilling, sawing, scratching, scraping, clamping, retracting, clipping or similar procedures, without connection to any active medical device and which can be reused after appropriate procedures have been carried out.

1.4.Active medical deviceU.K.

Any medical device operation of which depends on a source of electrical energy or any source of power other than that directly generated by the human body or gravity and which acts by converting this energy. Medical devices intended to transmit energy, substances or other elements between an active medical device and the patient, without any significant change, are not considered to be active medical devices.[F1 Stand alone software is considered to be an active medical device.]

1.5.Active therapeutical deviceU.K.

Any active medical device, whether used alone or in combination with other medical devices, to support, modify, replace or restore biological functions or structures with a view to treatment or alleviation of an illness, injury or handicap.

1.6.Active device for diagnosisU.K.

Any active medical device, whether used alone or in combination with other medical devices, to supply information for detecting, diagnosing, monitoring or treating physiological conditions, states of health, illnesses or congenital deformities.

[F21.7. Central circulatory system U.K.

For the purposes of this Directive, central circulatory system means the following vessels:

arteriae pulmonales, aorta ascendens, arcus aorta, aorta descendens to the bifurcatio aortae, arteriae coronariae, arteria carotis communis, arteria carotis externa, arteria carotis interna, arteriae cerebrales, truncus brachiocephalicus, venae cordis, venae pulmonales, vena cava superior, vena cava inferior.]

1.8.Central nervous systemU.K.

For the purposes of this Directive, ‘central nervous system’ means brain, meninges and spinal cord.

II.IMPLEMENTING RULESU.K.

2.Implementing rulesU.K.

2.1.Application of the classification rules shall be governed by the intended purpose of the devices.U.K.
2.2.If the device is intended to be used in combination with another device, the classification rules shall apply separately to each of the devices. Accessories are classified in their own right separately from the device with which they are used.U.K.
2.3.Software, which drives a device or influences the use of a device, falls automatically in the same class.U.K.
2.4.If the device is not intended to be used solely or principally in a specific part of the body, it must be considered and classified on the basis of the most critical specified use.U.K.
2.5.If several rules apply to the same device, based on the performance specified for the device by the manufacturer, the strictest rules resulting in the higher classification shall apply.U.K.
[F12.6. In calculating the duration referred to in Section 1.1 of Chapter I, continuous use means an uninterrupted actual use of the device for the intended purpose . However where usage of a device is discontinued in order for the device to be replaced immediately by the same or an identical device this shall be considered an extension of the continuous use of the device.] U.K.

III.CLASSIFICATIONU.K.

1.Non-invasive devicesU.K.

1.1.Rule 1U.K.

All non-invasive devices are in Class I, unless one of the rules set out hereinafter applies.

1.2.Rule 2U.K.

All non-invasive devices intended for channelling or storing blood, body liquids or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body are in Class IIa:

  • if they may be connected to an active medical device in Class IIa or a higher class,

  • if they are intended for use for storing or channelling blood or other body liquids or for storing organs, parts of organs or body tissues,

in all other cases they are in Class I.

1.3.Rule 3U.K.

All non-invasive devices intended for modifying the biological or chemical composition of blood, other body liquids or other liquids intended for infusion into the body are in Class IIb, unless the treatment consists of filtration, centrifugation or exchanges of gas, heat, in which case they are in Class IIa.

1.4.Rule 4U.K.

All non-invasive devices which come into contact with injured skin:

  • are in Class I if they are intended to be used as a mechanical barrier, for compression or for absorption of exudates,

  • are in Class IIb if they are intended to be used principally with wounds which have breached the dermis and can only heal by secondary intent,

  • are in Class IIa in all other cases, including devices principally intended to manage the micro-environment of a wound.

2.Invasive devicesU.K.

2.1.Rule 5U.K.

[F2All invasive devices with respect to body orifices, other than surgically invasive devices and which are not intended for connection to an active medical device or which are intended for connection to an active medical device in Class I:]

  • are in Class I if they are intended for transient use,

  • are in Class IIa if they are intended for short-term use, except if they are used in the oral cavity as far as the pharynx, in an ear canal up to the ear drum or in a nasal cavity, in which case they are in Class I,

  • are in Class IIb if they are intended for long-term use, except if they are used in the oral cavity as far as the pharynx, in an ear canal up to the ear drum or in a nasal cavity and are not liable to be absorbed by the mucous membrane, in which case they are in Class IIa.

All invasive devices with respect to body orifices, other than surgically invasive devices, intended for connection to an active medical device in Class IIa or a higher class, are in Class IIa.

[F22.2. Rule 6 U.K.

All surgically invasive devices intended for transient use are in Class IIa unless they are:

  • intended specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body, in which case they are in Class III,

  • reusable surgical instruments, in which case they are in Class I,

  • intended specifically for use in direct contact with the central nervous system, in which case they are in Class III,

  • intended to supply energy in the form of ionising radiation in which case they are in Class IIb,

  • intended to have a biological effect or to be wholly or mainly absorbed in which case they are in Class IIb,

  • intended to administer medicines by means of a delivery system, if this is done in a manner that is potentially hazardous taking account of the mode of application, in which case they are in Class IIb.]

2.3.Rule 7U.K.

All surgically invasive devices intended for short-term use are in Class IIa unless they are intended:

  • [F2either specifically to control, diagnose, monitor or correct a defect of the heart or of the central circulatory system through direct contact with these parts of the body, in which case they are in Class III,]

  • or specifically for use in direct contact with the central nervous system, in which case they are in Class III,

  • or to supply energy in the form of ionizing radiation in which case they are in Class IIb,

  • or to have a biological effect or to be wholly or mainly absorbed in which case they are in Class III,

  • or to undergo chemical change in the body, except if the devices are placed in the teeth, or to administer medicines, in which case they are in Class IIb.

2.4.Rule 8U.K.

All implantable devices and long-term surgically invasive devices are in Class IIb unless they are intended:

  • to be placed in the teeth, in which case they are in Class IIa,

  • to be used in direct contact with the heart, the central circulatory system or the central nervous system, in which case they are in Class III,

  • to have a biological effect or to be wholly or mainly absorbed, in which case they are in Class III,

  • or to undergo chemical change in the body, except if the devices are placed in the teeth, or to administer medicines, in which case they are in Class III.

3.Additional rules applicable to active devicesU.K.

3.1.Rule 9U.K.

All active therapeutic devices intended to administer or exchange energy are in Class IIa unless their characteristics are such that they may administer or exchange energy to or from the human body in a potentially hazardous way, taking account of the nature, the density and site of application of the energy, in which case they are in Class IIb.

All active devices intended to control or monitor the performance of active therapeutic devices in Class IIb, or intended directly to influence the performance of such devices are in Class IIb.

3.2.Rule 10U.K.

Active devices intended for diagnosis are in Class IIa:

  • if they are intended to supply energy which will be absorbed by the human body, except for devices used to illuminate the patient's body, in the visible spectrum,

  • if they are intended to image in vivo distribution of radiopharmaceuticals,

  • if they are intended to allow direct diagnosis or monitoring of vital physiological processes, unless they are specifically intended for monitoring of vital physiological parameters, where the nature of variations is such that it could result in immediate danger to the patient, for instance variations in cardiac performance, respiration, activity of CNS in which case they are in Class IIb.

Active devices intended to emit ionizing radiation and intended for diagnostic and therapeutic interventional radiology including devices which control or monitor such devices, or which directly influence their performance, are in Class IIb.

Rule 11U.K.

All active devices intended to administer and/or remove medicines, body liquids or other substances to or from the body are in Class IIa, unless this is done in a manner:

  • that is potentially hazardous, taking account of the nature of the substances involved, of the part of the body concerned and of the mode of application in which case they are in Class IIb.

3.3.Rule 12U.K.

All other active devices are in Class I.

4.Special RulesU.K.

4.1.Rule 13U.K.

All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, as defined in Article 1 of Directive [F22001/83/EC], and which is liable to act on the human body with action ancillary to that of the devices, are in Class III.

[F2All devices incorporating, as an integral part, a human blood derivative are in Class III.]

4.2.Rule 14U.K.

All devices used for contraception or the prevention of the transmission of sexually transmitted diseases are in Class IIb, unless they are implantable or long term invasive devices, in which case they are in Class III.

4.3.Rule 15U.K.

All devices intended specifically to be used for disinfecting, cleaning, rinsing or, when appropriate, hydrating contact lenses are in Class IIb.

All devices intended specifically to be used for disinfecting medical devices are in Class IIa. [F1Unless they are specifically to be used for disinfecting invasive devices in which case they are in Class IIb.]

This rule does not apply to products that are intended to clean medical devices other than contact lenses by means of physical action.

4.4.Rule 16U.K.

[F2Devices] specifically intended for recording of X-ray diagnostic images are in Class IIa.

4.5.Rule 17U.K.

All devices manufactured utilizing animal tissues or derivatives rendered non-viable are Class III except where such devices are intended to come into contact with intact skin only.

5.Rule 18U.K.

By derogation from other rules, blood bags are in Class IIb.

Back to top

Options/Help

Print Options

You have chosen to open the Whole Directive

The Whole Directive you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

You have chosen to open Schedules only

The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.

Would you like to continue?

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources